Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.715 USD | -2.00% | +13.00% | +200.00% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.00% | 321M | |
+29.34% | 682B | |
+30.35% | 586B | |
-3.30% | 364B | |
+18.02% | 327B | |
+3.94% | 285B | |
+15.91% | 240B | |
+10.40% | 209B | |
-8.38% | 203B | |
+7.65% | 165B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Transcript : Nektar Therapeutics, Q3 2022 Earnings Call, Nov 03, 2022